A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma

被引：0
作者：
Soushi Ibata
Tsutomu Sato
Hiroyuki Kuroda
Yasuhiro Nagamachi
Satoshi Iyama
Akihito Fujimi
Yusuke Kamihara
Yuichi Konuma
Masahiro Yoshida
Ayumi Tatekoshi
Akari Hashimoto
Hiroto Horiguchi
Kaoru Ono
Kazuyuki Murase
Kohichi Takada
Koji Miyanishi
Masayoshi Kobune
Yasuo Hirayama
Junji Kato
机构：
[1] Sapporo Medical University School of Medicine,Department of Medical Oncology and Hematology
[2] Steel Memorial Muroran Hospital,Gastroenterology and Hematology/Clinical Oncology, Internal Medicine
[3] Kiyota Hospital,Department of Hematology
[4] Oji General Hospital,Department of Hematology and Oncology
[5] Asahikawa Red Cross Hospital,Department of Hematology and Oncology
[6] Higashi Sapporo Hospital,Division of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Multiple myeloma; Consolidation/maintenance; Bortezomib; Lenalidomide; Dexamethasone; VRD;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1041 / 1049
页数：8
相关论文
共 86 条
  • [1] Palumbo A(2013)Role of consolidation/maintenance therapy in multiple myeloma Clin Lymphoma Myeloma Leuk 13 S349-S354
  • [2] Mina R(2011)Multiple myeloma N Engl J Med 364 1046-1060
  • [3] Cerrato C(2006)Maintenance therapy with thalidomide improves survival in patients with multiple myeloma Blood 108 3289-3294
  • [4] Cavallo F(2009)Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure J Clin Oncol 27 1788-1793
  • [5] Palumbo A(2006)Thalidomide and hematopoietic-cell transplantation for multiple myeloma N Engl J Med 354 1021-1030
  • [6] Anderson K(2012)The role of maintenance thalidomide therapy in multiple myeloma: MRC myeloma IX results and meta-analysis Blood 119 7-15
  • [7] Attal M(2010)Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma Haematologica 95 1548-1554
  • [8] Harousseau J-L(2010)A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma Blood 115 1113-1120
  • [9] Leyvraz S(2012)Continuous lenalidomide treatment for newly diagnosed multiple myeloma N Engl J Med 366 1759-1769
  • [10] Spencer A(2012)Lenalidomide after stem-cell transplantation for multiple myeloma N Engl J Med 366 1770-1781
123456789